This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Sexually Transmitted Diseases  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Rita Mangione-Smith, MD, MPH; Elizabeth A. McGlynn, PhD; Liisa Hiatt, MS

Arch Pediatr Adolesc Med. 2000;154:1108-1113.

Objective  To measure the proportion of sexually active females aged 15 to 25 years who received a screening test for Chlamydia trachomatis infection during the previous year.

Design  Administrative data were used to identify females in the target age range who were likely to be sexually active. Medical record data were reviewed for a sample to determine whether the administrative algorithm was acceptable. Laboratory claims data and medical record data were used to identify females who had had a screening test for chlamydia.

Setting  Four geographically dispersed US managed health care plans.

Patients  We studied 19,214 sexually active females aged 15 to 25 years continuously enrolled for calendar year 1997 in 1 of 4 major US health plans who had a visit to their health care provider during that year. Sexual activity was determined using an algorithm designed for use with administrative data.

Main Outcome Measure  Rates of chlamydia screening among sexually active females aged 15 to 25 years.

Results  The proportion of females aged 15 to 25 years identified as sexually active by the administrative data algorithm in the 4 health plans was similar (43%-54%; P = .79). However, substantial variation was found in rates of chlamydia screening for eligible females in these 4 health plans (2%-42%; P<.001). Plans varied considerably in the types of visits (eg, sexually transmitted disease screening or pregnancy) that determined eligibility for the measure.

Conclusions  A measure of health plan performance on screening for chlamydia in young females using administrative data is feasible and provides useful results despite some flaws in estimation. There is room for improvement in rates of chlamydia screening in sexually active females aged 15 to 25 years.

From the Department of Pediatrics, University of California, Los Angeles (Dr Mangione-Smith), and the RAND Health Program, Santa Monica, Calif (Dr McGlynn and Ms Hiatt).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chlamydia Screening Among Sexually Active Young Female Enrollees of Health Plans--United States, 2000-2007
JAMA 2009;302:620-621.
FULL TEXT  

Chlamydia Screening Among Sexually Active Young Female Enrollees of Health Plans--United States, 1999-2001
JAMA 2004;292:2569-2570.
FULL TEXT  

Chlamydia Screening: Expanding the Scope
Stamm
ANN INTERN MED 2004;141:570-572.
FULL TEXT  

Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United States
Miller et al.
JAMA 2004;291:2229-2236.
ABSTRACT | FULL TEXT  

Evaluating the Quality of Sexual Health Care Provided to Adolescents in Medicaid Managed Care: A Comparison of Two Data Sources
Downey et al.
American Journal of Medical Quality 2004;19:2-11.
ABSTRACT  

Provision of Sexual Health Services to Adolescent Enrollees in Medicaid Managed Care
Lafferty et al.
AJPH 2002;92:1779-1783.
ABSTRACT | FULL TEXT